New Report Forecasts Sepsis Drug Market

The main driver of sepsis market growth will be the launch of multiple first-in-class products that directly manage sepsis and septic shock, including monoclonal antibodies (mAbs), new antibiotics, and drugs with novel mechanisms of action.

The sepsis and septic shock market is expected to experience significant growth from $3.48 billion in 2020 to $7.5 billion by 2030 across the US, France, Germany, Italy, Spain, UK, and Japan at a compound annual growth rate (CAGR) of 8%, according to GlobalData, a leading data, and analytics company.

It is estimated that sepsis accounts for one in five deaths globally and the World Health Organization (WHO) has stated that sepsis is a leading cause of death in hospitals. Additionally, sepsis is one of the most expensive conditions to treat in the US care system.

Sepsis / Septicemia-Causes-Symptoms-Treatment-Complications
Septicemia or sepsis is a serious illness wherein a patient develops symptoms due to presence of microbes or their toxins in the blood. Septicemia or sepsis is caused by bacteria, viruses and fungi.

‘Global sepsis market set to reach $7.5 billion by 2030 with the launch of new first-in-class products.’

However, there has been limited development in the sepsis market within the last two decades.

This is further highlighted by the very public withdrawal of Eli Lilly’s Xigris in 2011 following studies showing that it did not show any mortality benefit for septic patients. As of today, generic antibiotics and supportive therapies dominate the market.

The latest report identifies that a high level of unmet need for sepsis and septic shock, which remains an untapped market associated with nearly two million hospitalizations in the US in 2020.

World Sepsis Day 2021 � Stop Sepsis, Save Lives
Each year on September 13th, world sepsis day is celebrated as a collaborative effort of the Global Sepsis Alliance to organize events for sepsis awareness.

The current treatment options have remained to be antibiotics and supportive therapy for the last two decades, with no sepsis-specific products that target the disease itself.

Several first-in-class products for sepsis and septic shock will coexist simultaneously by 2030, including new biologics and small molecules for the treatment of sepsis and septic shock.

Sepsis Deaths Can Be Easily Prevented - World Sepsis Day
World sepsis day (WSD) is observed on the 13th September to raise awareness about sepsis which is the leading cause of death due to infection and can be easily prevented by early diagnosis and treatment.

However, the global impact of new products in reducing the overall sepsis burden will depend on the cost-effectiveness of these drugs, given that generic drugs currently dominate the market, as well as how the new drugs are eventually integrated into national treatment policies.

Test Your Knowledge on Sepsis
Sepsis or septicemia occurs when the body responds in an exaggerated manner to infection resulting in bloodstream infection with severe tissue damage and multiple organ failure and death if not managed promptly. Take this quiz to test your knowledge on sepsis.

Source-Medindia